Suppr超能文献

硝苯地平缓释片与阿替洛尔治疗老年轻至中度高血压的对照试验

Comparative trial of nifedipine retard and atenolol in the treatment of elderly patients with mild to moderate hypertension.

作者信息

Clamp M, Holmes B, Wilcox R

机构信息

Health Centre, Radcliffe-on-Trent, Nottingham, UK.

出版信息

J Hum Hypertens. 1990 Oct;4(5):557-63.

PMID:2283646
Abstract

Forty-one elderly patients with mild to moderate hypertension (resting diastolic blood pressure 100-130 mmHg after an eight week placebo run-in phase) were randomised to a double-blind parallel group comparison of nifedipine retard 10 mg twice daily or atenolol 50 mg once daily. If the resting diastolic pressure exceeded 95 mmHg after four weeks of treatment the dose(s) were doubled for a further four weeks. Initial sitting blood pressures were 187 +/- 21/105 +/- 5 mmHg in the nifedipine group and 181 +/- 19/106 +/- 6 in the atenolol group. At four weeks, eight patients given nifedipine and nine given atenolol had their doses doubled. At eight weeks sitting blood pressures were 159 +/- 19/85 +/- 7 and 162 +/- 21/87 +/- 8 respectively, with 18/20 patients given nifedipine and 16/21 given atenolol having a sitting diastolic pressure equal to or less than 95 mmHg. One patient given nifedipine was withdrawn because of unacceptable ankle oedema and one given atenolol withdrawn because of worsening angina. Both drugs were equally acceptable to the patients and neither caused a change in their sense of well-being.

摘要

41例轻度至中度高血压老年患者(经过8周安慰剂导入期后静息舒张压为100 - 130 mmHg)被随机分为双盲平行组,分别接受硝苯地平缓释片10 mg每日2次或阿替洛尔50 mg每日1次的治疗。若治疗4周后静息舒张压超过95 mmHg,则剂量加倍再治疗4周。硝苯地平组初始坐位血压为187±21/105±5 mmHg,阿替洛尔组为181±19/106±6 mmHg。4周时,8例服用硝苯地平的患者和9例服用阿替洛尔的患者剂量加倍。8周时坐位血压分别为159±19/85±7 mmHg和162±21/87±8 mmHg,服用硝苯地平的患者中有18/20例、服用阿替洛尔的患者中有16/21例静息舒张压等于或低于95 mmHg。1例服用硝苯地平的患者因不可接受的踝部水肿退出研究,1例服用阿替洛尔的患者因心绞痛加重退出研究。两种药物对患者来说同样可以接受,且均未引起患者幸福感的改变。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验